Abstract
Background: Oral squamous cell carcinoma (OSCC) requires reliable prognostic markers for treatment planning. Intratumoral budding (ITB) is a histopathological parameter shown to have prognostic relevance in several malignancies. This study evaluated the prognostic utility of ITB in pre‐operative OSCC biopsies compared with World Health Organization (WHO) histological grading. Methods: An ambispective cohort of 42 pre‐operative OSCC cases (well and moderately differentiated squamous cell carcinoma) with corresponding resection reports (January 2022–April 2025) was analyzed. ITB was assessed on hematoxylin and eosin–stained sections using International Tumor Budding Consensus Conference criteria, including TB0. Clinicopathological parameters and survival outcomes—disease‐free survival (DFS) and overall survival (OS)—were evaluated. Results: ITB positivity correlated significantly with higher nodal stage, tumor–node–metastasis stage, depth of invasion, perineural invasion, and extracapsular spread (all p < 0.05). ITB‐positive cases showed reduced DFS ( p = 0.023) and OS ( p = 0.019), with worsening DFS across increasing ITB grades ( p = 0.018). Cox regression demonstrated higher hazard ratios for ITB positivity (DFS: HR 47.93, 95% CI 0.12–18,571.86; OS: HR 49.80, 95% CI 0.14–18,238.87), though not statistically significant. WHO grading showed no significant survival associations. Conclusion: In this single‐center, small cohort, ITB demonstrated stronger associations with adverse features and survival than WHO grading, warranting validation in larger cohorts.

This publication has 25 references indexed in Scilit: